Preoperative axillary ultrasound and MRI effectively predict sentinel lymph node status, guiding safe SLNB de-escalation in ...

A new surgical technique for women with high-risk Ductal Carcinoma In-Situ (DCIS), known as a ‘delayed’ sentinel lymph node biopsy, is part of a new campaign centered on saving patients’ lymph nodes ...

Triple-negative breast cancer. A clinicopathologic study of 113 cases and comparison with 55 cases with triple positive breast cancer: A matched-control analysis No significant financial relationships ...

Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or ...

A phase II study of capecitabine (CAP) plus PHY906 in patients (pts) with advanced pancreatic cancer (APC) No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the ...

Trials evaluating the omission of completion axillary-lymph-node dissection in patients with clinically node-negative breast cancer and sentinel-lymph-node metastases have been compromised by limited ...

Information obtained from a new application of photoacoustic tomography (PAT) is worth its weight in gold to breast cancer patients. For the first time, Lihong Wang, Ph.D., Gene K. Beare Distinguished ...

One of the most important incremental steps in breast cancer has been to lessen the amount of axillary surgery that is needed to stage breast cancer. Sentinel node biopsy appears to lead a much lower ...

In the AXSANA/EUBREAST 3(R) study, researchers compared data about recurrence outcomes of more-invasive and less-invasive lymph node procedures.

Please provide your email address to receive an email when new articles are posted on . Skipping sentinel lymph node biopsy can be considered for node-negative, HR-positive, HER2-negative early breast ...

PHILADELPHIA, Aug. 23 — Breast cancer tends to progress to nearby lymph nodes, but surgeons can find it difficult to determine what tissue to remove with the breast tumor and what to leave intact.